Komori
Alfresa Holdings (2784) · FactFirst stated

FY2020-Q3 Revenue Growth and Profit Decline in the Self-Medication Wholesale Business

First written in FY2020-Q3. . Latest entry: FY2020-Q3.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Higher Revenue but Lower Profit Due to Rising Costs in the Self-Medication Wholesale BusinessA theme 1 companies write about · 1 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2020-Q3First statedAnnual report

    「当セグメントの当第３四半期連結累計期間の業績は、インバウンド需要の減少ならびに人手不足による人件費・物流費の高騰および改正消費税法施行に伴うシステム改修などによるコスト増により、売上高2,048億57百万円(前年同期比0.7％増)、営業利益18億76百万円(同10.3％減)となりました。」

    セルフメディケーション卸売事業は増収となった一方、インバウンド需要減少、人件費・物流費高騰、システム改修コストなどにより減益となった。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Alfresa Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.